Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05014815
Title Ociperlimab With Tislelizumab and Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors BeiGene
Indications

lung non-small cell carcinoma

Therapies

BGBA1217 + Tislelizumab

Tislelizumab

Age Groups: senior | adult
Covered Countries USA | FRA | ESP | AUT

Additional content available in CKB BOOST